floorhole9

About

1st Human being Usage of RUC-4: A Nonactivating Second-Generation Small-Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Created for Subcutaneous Point-of-Care Treating ST-Segment-Elevation Myocardial Infarction.